Gypenosides Protect Orbital Fibroblasts in Graves Ophthalmopathy Via Anti-Inflammation and Anti-Fibrosis Effects

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2020 May 29

PMID 32462203

Citations 13

Authors

Haoyu Li

Chao Ma

Wei Liu

Jianfeng He

Kaijun Li

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the effect of Gypenosides (Gyps) on the inflammation and fibrosis in orbital fibroblasts (OFs) in Graves ophthalmopathy (GO).

Methods: Bioinformatics analyses were performed to identify the enriched genes and signaling pathways related to Gyps function. For ex vivo experiments, OFs were cultured from orbital connective tissues from patients with GO. OF proliferation was estimated by Cell Counting Kit-8 assay. Effects of Gyps treatment on interleukin (IL)-1β-induced inflammation and transforming growth factor-β1 (TGF-β1)-induced fibrosis were evaluated by real-time quantitative PCR (RT-qPCR), enzyme-linked immunosorbent assay (ELISA), and Western blotting. OFs were treated with IL-1β or TGF-β1 in the absence or presence of Gyps pretreatment, and the levels of related mRNA or proteins were evaluated by RT-qPCR or ELISA.

Results: Eight inflammation-related target genes and nine fibrosis-related target genes were screened out. These genes were mainly enriched in pathways corresponding to inflammation and fibrosis, respectively. IL-1β-induced upregulation of inflammatory cytokines, and TGF-β-induced upregulation of fibrotic mediators in OFs were downregulated by Gyps. Moreover, Gyps reduced the activation of Toll like receptors 4/nuclear factor-κ B signaling and TGF-β1/SMAD2/SMAD4 signaling in GO OFs.

Conclusions: Gyps could protect GO-derived OFs against IL-1β-induced inflammation and TGF-β1-induced fibrosis. Thus Gyps might have therapeutic potential on inflammation and fibrosis in GO.

Citing Articles

An L-type calcium channel blocker nimodipine exerts anti-fibrotic effects by attenuating TGF-β1 induced calcium response in an in vitro model of thyroid eye disease.

Chen Q, Pan Y, Hu Y, Chen G, Chen X, Xie Y Eye Vis (Lond). 2024; 11(1):37.

PMID: 39237996 PMC: 11378575. DOI: 10.1186/s40662-024-00401-5.

Thyroid-associated ophthalmopathy: the role of oxidative stress.

Ma C, Li H, Lu S, Li X Front Endocrinol (Lausanne). 2024; 15:1400869.

PMID: 39055057 PMC: 11269105. DOI: 10.3389/fendo.2024.1400869.

Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy.

Zhang X, Zhao Q, Li B Front Pharmacol. 2023; 14:1217253.

PMID: 38035032 PMC: 10687425. DOI: 10.3389/fphar.2023.1217253.

17β-estradiol inhibits TGF-β-induced collagen gel contraction mediated by human Tenon fibroblasts Smads and MAPK signaling pathways.

Yang C, Liu M, Li Y, Xu Z, Liu Y, Guo Z Int J Ophthalmol. 2023; 16(9):1441-1449.

PMID: 37724268 PMC: 10475634. DOI: 10.18240/ijo.2023.09.10.

Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves' orbitopathy.

Cao J, Qi X, Wang N, Chen Y, Xie B, Ma C J Endocrinol Invest. 2023; 46(10):2005-2016.

PMID: 36849849 DOI: 10.1007/s40618-023-02033-3.

References

Sahli E, Gunduz K . Thyroid-associated Ophthalmopathy. Turk J Ophthalmol. 2017; 47(2):94-105. PMC: 5384127. DOI: 10.4274/tjo.80688. View

Yoon J, Lee H, Chae M, Lee E . Autophagy is involved in the initiation and progression of Graves' orbitopathy. Thyroid. 2015; 25(4):445-54. DOI: 10.1089/thy.2014.0300. View

Hwang C, Afifiyan N, Sand D, Naik V, Said J, Pollock S . Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci. 2009; 50(5):2262-8. PMC: 2752347. DOI: 10.1167/iovs.08-2328. View

Wiersinga W, Prummel M . Pathogenesis of Graves' ophthalmopathy--current understanding. J Clin Endocrinol Metab. 2001; 86(2):501-3. DOI: 10.1210/jcem.86.2.7338. View

Tanner M, Bu X, Steimle J, Myers P . The direct release of nitric oxide by gypenosides derived from the herb Gynostemma pentaphyllum. Nitric Oxide. 1999; 3(5):359-65. DOI: 10.1006/niox.1999.0245. View

Bae U, Park E, Park J, Jung S, Ham H, Yu K . Gypenoside UL4-Rich Gynostemma pentaphyllum Extract Exerts a Hepatoprotective Effect on Diet-Induced Nonalcoholic Fatty Liver Disease. Am J Chin Med. 2018; 46(6):1315-1332. DOI: 10.1142/S0192415X18500696. View

Huang L, Jiang P, Feghali-Bostwick C, Reddy S, Garcia J, Natarajan V . Lysocardiolipin acyltransferase regulates TGF-β mediated lung fibroblast differentiation. Free Radic Biol Med. 2017; 112:162-173. DOI: 10.1016/j.freeradbiomed.2017.07.023. View

Huang D, Sherman B, Lempicki R . Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2008; 37(1):1-13. PMC: 2615629. DOI: 10.1093/nar/gkn923. View

Higashi A, Aronow B, Dressler G . Expression Profiling of Fibroblasts in Chronic and Acute Disease Models Reveals Novel Pathways in Kidney Fibrosis. J Am Soc Nephrol. 2018; 30(1):80-94. PMC: 6317603. DOI: 10.1681/ASN.2018060644. View

10.

Shu D, Lovicu F . Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis. Prog Retin Eye Res. 2017; 60:44-65. PMC: 5600870. DOI: 10.1016/j.preteyeres.2017.08.001. View

11.

Gauhar R, Hwang S, Jeong S, Kim J, Song H, Park D . Heat-processed Gynostemma pentaphyllum extract improves obesity in ob/ob mice by activating AMP-activated protein kinase. Biotechnol Lett. 2012; 34(9):1607-16. DOI: 10.1007/s10529-012-0944-1. View

12.

Macias M, Martin-Malpartida P, Massague J . Structural determinants of Smad function in TGF-β signaling. Trends Biochem Sci. 2015; 40(6):296-308. PMC: 4485443. DOI: 10.1016/j.tibs.2015.03.012. View

13.

Shimizu T . Inflammation-inducing Factors of Mycoplasma pneumoniae. Front Microbiol. 2016; 7:414. PMC: 4814563. DOI: 10.3389/fmicb.2016.00414. View

14.

Aktan F, Henness S, Roufogalis B, Ammit A . Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-kappaB-mediated iNOS protein expression. Nitric Oxide. 2003; 8(4):235-42. DOI: 10.1016/s1089-8603(03)00032-6. View

15.

Huang T, Tran V, Roufogalis B, Li Y . Gypenoside XLIX, a naturally occurring PPAR-alpha activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial cells. Eur J Pharmacol. 2007; 565(1-3):158-65. DOI: 10.1016/j.ejphar.2007.03.013. View

16.

Li L, Jiao L, Lau B . Protective effect of gypenosides against oxidative stress in phagocytes, vascular endothelial cells and liver microsomes. Cancer Biother. 1993; 8(3):263-72. DOI: 10.1089/cbr.1993.8.263. View

17.

Friedman S . Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; 134(6):1655-69. PMC: 2888539. DOI: 10.1053/j.gastro.2008.03.003. View

18.

Chen B, Tsui S, Smith T . IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. J Immunol. 2005; 175(2):1310-9. DOI: 10.4049/jimmunol.175.2.1310. View

19.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

20.

Song Y, Dong S, Wei B, Liu P, Zhang Y, Su S . Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data. PLoS One. 2017; 12(3):e0173598. PMC: 5349658. DOI: 10.1371/journal.pone.0173598. View